title: Gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia.
authors: From the Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY (R.J.H.); and NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Imperial College, London, UK (A.R.L.). roger.hajjar@mssm.edu.
authors: Roger J
authors: RJ
authors: Hajjar
authors: From the Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai, New York, NY (R.J.H.); and NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Imperial College, London, UK (A.R.L.).
authors: Alexander R
authors: AR
authors: Lyon
mesh_terms: D000375:Aging; D000818:Animals; D002155:Calsequestrin / Q000235:genetics*; D000229:Dependovirus / Q000235:genetics*; D005260:Female; D008297:Male; D017180:Tachycardia, Ventricular / Q000628:therapy*; D000098850:Polymorphic Catecholaminergic Ventricular Tachycardia
chemical_list: D002155:Calsequestrin; C514388:casq2 protein, mouse
keywords: Editorials; calsequestrin; genetic therapy; polymorphic catecholaminergic ventricular tachycardia; ryanodine receptor release channel; sarcoplasmic reticulum